Astrapharm Chilli Brand Plaster
NDC Package 11993-000-03
Package Information
Astrapharm Chilli Brand (capsaicin) plasters is clean and dry affected area, peel plaster away from paper backing and apply to the affected area by pressing edges down firmly.If needed, cut plaster into smaller pieces.Adults and children 12 years of age and over: Apply to affected area not more than 3 times daily. This formulation utilizes a plaster delivery system. Marketed by Dersan Pharmaceutical Co., Ltd, this product is identified by NDC 11993-000 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1111739 - capsaicin 0.25 % Medicated Patch
- RxCUI: 1111739 - capsaicin 0.0025 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11993 - Dersan Pharmaceutical Co., Ltd
- 11993-000 - Astrapharm Chilli Brand
- 11993-000-03 - 160 PACKAGE in 1 PACKAGE / 8 PATCH in 1 PACKAGE (11993-000-33) / .25 g in 1 PATCH
- 11993-000 - Astrapharm Chilli Brand
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11993-000). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11993-000-03 identifies a specific commercial package of 160 package in 1 package / 8 patch in 1 package (11993-000-33) / .25 g in 1 patch of Astrapharm Chilli Brand, a human over the counter drug labeled by Dersan Pharmaceutical Co., Ltd. This plaster is formulated for topical use and contains capsaicin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dersan Pharmaceutical Co., Ltd on March 01, 2020. The current certification is valid through December 31, 2026.
How is this Dersan Pharmaceutical Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11993000003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.